STOCK TITAN

Village Farms International Comments on Delayed Marijuana Rescheduling Process

(Neutral)
(Neutral)
Tags

Village Farms International (NASDAQ: VFF) has issued statements regarding delays in the marijuana rescheduling process due to ongoing litigation against the Drug Enforcement Administration (DEA). This follows a January 13, 2025 Administrative Law Judge (ALJ) order granting an interlocutory appeal request. The ALJ heavily criticized the DEA's conduct, describing it as 'unprecedented,' 'astonishing,' and 'embarrassing.'

CEO Michael DeGiglio characterized the proceedings as an imperative administrative step and a symbolic victory against what the company views as a conflicted government agency. As the only cannabis operator participant in these proceedings, Village Farms expressed commitment to advocate for a fair process and cannabis reform. DeGiglio highlighted that despite majority public support for legalization and positive scientific research, prohibitionist efforts continue to impede progress in cannabis reform.

Loading...
Loading translation...

Positive

  • Selected as the only cannabis operator participant in DEA rescheduling proceedings
  • Gained legal momentum with favorable ALJ criticism of DEA conduct

Negative

  • Ongoing delays in marijuana rescheduling process affecting business outlook
  • Continued regulatory obstacles from DEA resistance to Schedule III designation

Insights

The administrative law judge's scathing criticism of the DEA's conduct in the marijuana rescheduling process represents a significant legal development. The unprecedented harsh language used by the ALJ - describing the DEA's behavior as "astonishing" and showing "grotesque lack of understanding" - could potentially influence future legal proceedings and regulatory decisions. While this delay might seem negative, it actually strengthens the legal position of cannabis companies by establishing a clear record of agency misconduct.

The interlocutory appeal grant is particularly noteworthy, as it allows for immediate review of certain aspects of the case before a final decision. This procedural victory could accelerate the timeline for potential reforms and create legal precedents affecting the entire cannabis industry. However, the battle between industry stakeholders and federal regulators highlights the complex regulatory environment that continues to impact cannabis companies' market valuations and operational capabilities.

For Village Farms and the broader cannabis sector, this regulatory conflict presents mixed implications. While the delay in rescheduling creates near-term uncertainty, VFF's prominent role as the sole cannabis operator participant in these proceedings enhances its industry leadership position. The company's market cap of $84.8M reflects current industry challenges, but its active engagement in regulatory reform could position it favorably if rescheduling eventually occurs.

The timing is particularly relevant given growing bipartisan support for cannabis reform and increasing adoption of cannabis as an alternative to opioids and alcohol. A successful rescheduling to Schedule III would significantly reduce tax burdens through 280E reform and potentially unlock institutional investment. However, investors should remain cautious as the pathway to regulatory change appears increasingly complex and contentious.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

– Company views delay as imperative administrative step and symbolic win for industry against conflicted DEA –

– Company condemns agency wrongdoing and commends judge for harsh criticism of government officials –

– CEO Michael DeGiglio affirms commitment to fight for reform; calls on Trump administration to correct past failures –

ORLANDO, Fla. and VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today issued a series of statements in response to delays in the marijuana rescheduling process resulting from its ongoing litigation against the Drug Enforcement Administration (“DEA”). The Company’s comments follow orders from the Administrative Law Judge (“ALJ”) on January 13, 2025 which granted a request for leave to file an interlocutory appeal, and referred to various DEA behavior and alleged misconduct as “unprecedented,” “astonishing,” “embarrassing,” and “demonstrate[ing] a puzzling and grotesque lack of understanding and poor judgment from high-level officials at a major federal agency.”

Michael DeGiglio, retired U.S. Navy captain, naval aviator and President, Chief Executive Officer and Founder of Village Farms commented, “We view the outcome of this past week’s proceedings as an imperative step in this administrative process, and a symbolic victory against a conflicted government agency which we believe has no current intention of recommending that cannabis be transferred to a Schedule III designation. We were given a voice in these proceedings through our selection as the only cannabis operator participant, and we intend to do everything we can to use that voice to fight for a fair and honest process with a successful outcome, and to help right the wrongdoings of decades of government corruption, bureaucracy, and the failed War on Drugs.”

Mr. DeGiglio continued, “We commend the ALJ for harsh criticism of the DEA’s defiance of this process and misconduct, which underscores our view that these proceedings are severely flawed due to the DEA’s conflicted role. A majority of Americans support legalization; millions of Americans from all walks of life increasingly rely on medical and recreational cannabis for therapeutic benefits and as substitutes for opioids and alcohol; and the scientific, medical, and civic research of cannabis conducted to date is overwhelmingly positive. The fact that the interests in health and safety of Americans continue to get steamrolled by prohibitionist efforts and competing interests is shameful and disgraceful. Our Company condemns this behavior unequivocally, and we implore the Trump administration to put a swift end to it and correct the failures of past leadership. Our constitution commences with ‘We the People’ and it’s time the federal government adhere to the will of the people and enact meaningful cannabis reform.”

About Village Farms International

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods. The Company has a strong foundation as the leading and longest-tenured leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada and is capitalizing on new high-growth opportunities in the cannabis and CBD categories in North America, the Netherlands and selected markets internationally.

In Canada, the Company's wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada’s best-selling brands. The Company also owns 80% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec.

Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to a growing list of international markets including Germany, the United Kingdom, Israel, and Australia. The Company is expanding its international presence with additional export contracts to new countries and customers in the Asia-Pacific and European regions, as well as select strategic investments in operating assets. In Europe, wholly-owned Leli Holland has one of 10 licences to grow and distribute recreational cannabis products.

In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms' cannabis success in Canada.

Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates clean energy from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated. This partnership reduces Vancouver’s greenhouse gas emissions by 475,000 metric tons of CO2 per year, equivalent to removing more than 100,000 vehicles off the road or the energy use equivalent of powering 51,300 homes for one year.

Contact Information
Sam Gibbons
Senior Vice President, Corporate Affairs
Village Farms International
Phone: (407) 936-1190 ext. 328
Email: sgibbons@villagefarms.com

FAQ

What is the status of Village Farms' (VFF) marijuana rescheduling litigation against the DEA?

As of January 13, 2025, an Administrative Law Judge granted an interlocutory appeal request and criticized the DEA's conduct in the proceedings, marking a procedural step forward in Village Farms' fight for cannabis rescheduling.

How is Village Farms (VFF) involved in the marijuana rescheduling process?

Village Farms is the only cannabis operator selected to participate in the DEA rescheduling proceedings, representing industry interests in the administrative process.

What was the Administrative Law Judge's response to DEA conduct in the VFF case?

The ALJ strongly criticized the DEA's behavior, describing it as 'unprecedented,' 'astonishing,' 'embarrassing,' and demonstrating 'poor judgment from high-level officials.'

What is Village Farms' (VFF) stance on DEA's position regarding Schedule III designation?

Village Farms believes the DEA has no current intention of recommending cannabis transfer to Schedule III designation and views the agency as conflicted in its role.